RECRUITING

Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).

Official Title

Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma (PAP-OP)

Quick Facts

Study Start:2022-11-01
Study Completion:2027-11-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06115772

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * \* Female patients with diagnosed HPV(+)OPSCC seen at the Mayo Clinic, Rochester
  2. * Age ≥ 18
  3. * Female partners of Mayo Clinic patients with diagnosed HPV(+)OPSCC
  4. * Patient has given permission to give his/her blood/saliva sample for research testing
  5. * Ability to complete questionnaire(s) by themselves or with assistance
  1. * \* HPV(-) OPSCC
  2. * Unable to provide informed consent
  3. * Unwilling to attend screening visit at Mayo Clinic site, if indicated
  4. * Unwilling/unable to complete surveys electronically

Contacts and Locations

Principal Investigator

Kathryn M. Van Abel, M.D.
PRINCIPAL_INVESTIGATOR
Mayo Clinic in Rochester

Study Locations (Sites)

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Kathryn M. Van Abel, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic in Rochester

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-01
Study Completion Date2027-11-01

Study Record Updates

Study Start Date2022-11-01
Study Completion Date2027-11-01

Terms related to this study

Additional Relevant MeSH Terms

  • Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma